Suchergebnis | Hamburg Open Science

Facetten

3 Einträge gefunden

Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†
2014 - Forschungsinformationssystem des UKE
Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab -- a translational project in the neoadjuvant GeparQuinto trial.
2012 - Forschungsinformationssystem des UKE
Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies.
2007 - Forschungsinformationssystem des UKE